Pediatric congenital heart disease
Conditions
Interventions
S group:Group S is the control group, induced by inhalation of sevoflurane, followed by intravenous injection of physiological saline
SD group:The SD group received intravenous injection of dexmedetomidine after induction with sevoflurane inhalation.
SE group:The SE group received intravenous injection of ketamine after induction with sevoflurane inhalation.
Sponsors
Yan‘an Hospital of Kunming City
Eligibility
Sex/Gender
All
Age
No minimum to 6 Years
Inclusion criteria
Inclusion criteria: 1. Age =6 years old; 2.ASA Grade ?~?; 3. Children with congenital heart disease undergoing dual-source CT examination; 4. Family members voluntarily participate in the clinical trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Children with potential ventilation and intubation difficulties have been evaluated; 2. Children who have experienced allergies or serious adverse reactions to the investigational drugs in the past; 3. Children with severe conduction abnormalities in cardiac electrophysiology; 4. Children with a history of neurological, psychiatric, or severe psychological disorders; 5. Children who do not comply with the prohibition of drinking and eating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor responses;Calm maintenance duration;Recovery duration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital signs;End-tidal carbon dioxide partial pressure;respiratory rate; | — |
Countries
China
Contacts
Public ContactPinyi Lv
Yan‘an Hospital of Kunming City
Outcome results
None listed